Tag Archives: Reduce

How To Cook Eggs To Reduce Your Risk Of Salmonella

How To Cook Eggs To Reduce Your Risk Of SalmonellaNearly 207 million eggs have been recalled for fear of a salmonella outbreak,

Yahoo News – Latest News & Headlines

Betsy DeVos Mulls The Fate Of Guidance Designed To Reduce Racial Bias In Schools

Betsy DeVos Mulls The Fate Of Guidance Designed To Reduce Racial Bias In SchoolsEducation Secretary Betsy DeVos met with a group of civil rights leaders,

Yahoo News – Latest News & Headlines

6 Real Ways We Can Reduce Gun Violence in America

6 Real Ways We Can Reduce Gun Violence in AmericaAmerica is the only developed country with such high rates of gun violence. Here are six steps we can take to reduce those numbers.

Yahoo News – Latest News & Headlines

5 Steps You Can Take to Reduce Your Risk of Breast Cancer Recurrence

[brightcove:5522509904001 default]

If you were diagnosed with breast cancer in the past, there’s a chance it may come back again. A large 2016 study in the Journal of Clinical Oncology found that women were most at risk for a recurrence within the first five years, and particularly one to two years after their surgery. While your healthcare team will keep a close eye on you—especially in the months following your treatment—there are a few steps that you can take that may reduce your risk of a cancer relapse.

Exercise for 150 minutes a week

It’s hard to understate the benefits of physical activity. A 2017 review published in the Canadian Medical Association Journal revealed that among women with a past breast cancer diagnosis, physical activity reduced mortality by about 40%. “Exercise may be the most influential modifiable risk factor in reducing breast cancer recurrence,” says Margaret Flowers, PhD, director of scientific communications and grants at the Breast Cancer Research Foundation. "While the research is still inconclusive about the biological underpinnings of this relationship, we know that exercise improves energy metabolism and reduces insulin levels. Other factors that are believed to be at play are a reduction in estrogen and metabolic hormones levels, as well as improved immune response."

RELATED: This Athleta Sports Bra Was Specifically Designed for Women Who Have Had a Mastectomy

Try not to gain weight

Most women gain some weight after they’ve been diagnosed with breast cancer, for a variety of possible reasons. They may feel too fatigued from chemo, for example, or experience a drop in their metabolic rate due to the drugs. Stress eating may also play a role. But several studies have shown that gaining weight during or after treatment increases the risk of recurrence, and reduces survival.

Fat cells release molecules called cytokines, which trigger inflammation, explains Flowers. Think of inflammation as an immune response that’s “much like the swelling you might see when a cut on your finger is healing,” she says. “A chronic, pro-inflammatory state supports the growth of tumor cells and makes them more aggressive, or more likely to spread to other tissues in the body.”

While it might be hard to avoid putting on any weight, the less you gain the better: The 2017 review noted that moderate weight gain—5 to 10% of a woman's body weight—was not linked to increased mortality, but a weight gain of more than 10% was.

RELATED: 57 Ways to Lose Weight Forever, According to Science

Cut back on saturated fats

The evidence is mixed, but the 2017 review noted that women who ate more saturated fats and high-fat dairy products had a greater risk of dying from breast cancer. That said, it’s unclear whether fatty fare is really to blame. The researchers pointed out that women who reduced their calories from fat also tended to lose weight (six pounds, on average), which is another way to protect against recurrence.

To get our top wellness tips delivered to your inbox, sign up for the Healthy Living newsletter

Consider an anti-estrogen drug

For women who have a higher-than-average risk of recurrence, doctors can prescribe medication. In particular, two drugs—called tamoxifen and raloxifene—can block estrogen in the breast cells, lowering the risk of developing breast cancer by about 40%, according to the American Cancer Society.

In order to see a long-term benefit, however, women need to take the pills for minimum of five years. The downside: the drugs can cause hot flashes, vaginal dryness, and a loss of libido. “It can be difficult for some women [to adhere to these drugs],” says Flowers, “but there are remedies for some of the side effects.” Treating the symptoms you’re experiencing can help you stick with the medication for as long as necessary, she says.

RELATED: 16 Celebrities Who Battled Breast Cancer

Don’t smoke—or overdo it on the booze

Women who continue to smoke after their diagnosis are more likely to die of breast cancer than their non-smoking counterparts, according to the 2017 review. It’s unclear whether cutting out cigarettes will reduce the odds of a recurrence, say the researchers, but it might help breast cancer survivors live longer.

Although the evidence is not yet conclusive, limiting your alcohol intake might help, too. Researchers have found that heavier drinkersthose who consumed more than 20 grams (or about a drink and a half) per daywere more likely to die of breast cancer than those drank less. In general, it’s a good idea to limit your intake to one drink a day.

www.health.com/breast-cancer/prevent-breast-cancer-recurrence “>
Breast Cancer – Health.com

Homicide in Baltimore breaks 'ceasefire' meant to reduce violence

Homicide in Baltimore breaks 'ceasefire' meant to reduce violenceCommunity leaders organized around the social media hashtag Baltimore Ceasefire issued a general plea that “no one kills anyone” during the 72 hours of Friday, Saturday and Sunday. By the end of July, Baltimore police reported a record 204 homicides, according to the Baltimore Sun, leading to the Baltimore Ceasefire movement. “There is a war going on in Baltimore right now.

Yahoo News – Latest News & Headlines

Here’s What Russia’s Decision to Reduce Diplomatic Staff Will Actually Mean

Here’s What Russia’s Decision to Reduce Diplomatic Staff Will Actually MeanIt’s likely Russian staff will feel it the most.

Yahoo News – Latest News & Headlines

Know Your Options to Reduce Student Loan Payments

Know Your Options to Reduce Student Loan PaymentsThe Student Loan Ranger receives many questions from readers. On occasion, we like to share some queries that other borrowers are likely to relate to .

Yahoo News – Latest News & Headlines

A new type of deal to reduce violence in Syria

A new type of deal to reduce violence in SyriaBEIRUT (AP) — The Russian plan to create safe zones in Syria, which came into effect Saturday, is the latest in a string of efforts to ease the country's horrendous violence. After past failures, this deal provides for the first time a mechanism to observe the cease-fire: Russian, Iranian and Turkish troops are to monitor compliance on the ground.

Yahoo News – Latest News & Headlines

Taking Hormone-Suppressing Drugs for 10 Years Could Reduce Risk of Breast Cancer Recurrence

MONDAY, June 6, 2016 (HealthDay News) — Many survivors of breast cancers that are sensitive to estrogen are advised to take hormone-suppressing drugs such as tamoxifen for five years, to cut their odds for a recurrence. Tamoxifen can have onerous side effects, however. Now, new research finds that taking an alternative, and less troublesome, class of medications for a full decade can reduce the risk for recurrence even more—without affecting a woman’s quality of life.

The newer class of hormone-suppressing drugs are called aromatase inhibitors, and include drugs such as letrozole (Femara), anastrozole (Arimidex) and exemestane (Aromasin).

“Aromatase inhibitors do not have all the side effects of tamoxifen and overall are much better tolerated than tamoxifen,” explained one breast cancer expert, Dr. Stephanie Bernik.

She believes the new study supports the benefit of aromatase inhibitors, and “women are much more likely to continue a longer course with this therapy” than with tamoxifen.

The study findings were presented Sunday in Chicago at the annual meeting of the American Society for Clinical Oncology (ASCO).

The new research involved more than 1,900 postmenopausal women who had already received five years of Femara treatment after surviving an early stage, hormone-sensitive form of breast cancer.

Some of the women continued receiving Femara for another five years, while others received a placebo.

Those who received Femara for the five additional years had a 34 percent lower risk of breast cancer recurrence than those who received the placebo, said a team led by Dr. Paul Goss, professor of medicine at Harvard Medical School.

There were also no significant differences in the women’s overall quality of life, or menopausal symptoms, between the two groups.

While the rate of breast cancer recurrence was lower with the extended therapy, the approach did not seem to have any effect on the women’s overall odds of dying from any cause, the researchers noted.

According to Goss, “women with early stage hormone-receptor positive breast cancer face an indefinite risk of relapse.

“The study provides direction for many patients and their doctors, confirming that prolonging aromatase inhibitor therapy can further reduce the risk of breast cancer recurrences,” said Goss, who also directs Breast Cancer Research at Massachusetts General Hospital.

In an ASCO news release, he said that “longer [aromatase inhibitor] therapy also showed a substantial breast cancer preventative effect in the opposite, healthy breast.”

For her part, Bernik noted that “many women don’t want to take tamoxifen because of the side effects.”

Those side effects can include “hot flashes, increased rate of uterine cancer, DVTs [clots in the deep veins of the leg that can break off and travel to the lung], increased rate of strokes, amongst other risks,” said Bernik, who is chief of surgical oncology at Lenox Hill Hospital, in New York City.

She said that many experts had assumed that a 10-year course of aromatase inhibitors like Femara might be a safe, attractive alternative to tamoxifen for patients—but no study had yet supported that notion.

“Therefore it is exciting that a new study backs the assumption of the added benefit of an extended course of the drug,” Bernik said.

According to background information supplied by the researchers, in 2012, there were more than 6 million women worldwide who had survived at least five years after a breast cancer diagnosis. Most of them had estrogen receptor-positive breast cancer, Goss’ team said.

Because the new findings were presented at a medical meeting, they should be considered preliminary until published in a peer-reviewed journal.

More information

The U.S. National Cancer Institute has more on breast cancer.

www.health.com/breast-cancer/longer-use-of-certain-drugs-cuts-recurrence-for-breast-cancer-survivors “>
Breast Cancer – Health.com

Products That May Reduce Your Risk of Breast Cancer

There is no proven link between breast cancer and household products, whether they be soap or water bottles. But many consumers, activists, and experts are concerned that a variety of goods contain hormone disruptors, chemicals that when absorbed into the body can mimic or interfere with hormones such as estrogen. Here are a few ways to play it safe.
www.health.com/health/gallery/0,,20306827,00.html “>
Breast Cancer – Health.com